Global Apheresis Market: Valued at USD 5.4 Billion in 2032 & to Achieve 6.60% CAGR in 2025-32
As per the research report by Report Cube, the Global Apheresis Market size was valued at nearly USD 5.4 billion in 2032, and is estimated to grow at a CAGR of about 6.60% during the forecast period, 2025-32.
Apheresis assists in filtering & purify blood, which is why it's employed in a number of medical procedures, including those for diabetes, renal disease, cancer, and rheumatoid arthritis. The sector is also experiencing growth owing to the rising cardiovascular disease among the elderly population. Moreover, the Apheresis Market companies are offering novel products with cutting-edge technology in order to surge their product portfolios and attain the best results. They are also expanding their brands internationally & forming corporate partnerships to meet consumer demands. To develop cutting-edge medical supplies for apheresis procedures, companies in this industry focus on research & development (R&D).
Additionally, CAR-T cell therapies, cell and gene therapies, sickle cell disorders, and symptom management all make use of advancements in automated apheresis equipment. These systems are used in therapeutic treatments and the development of cell-based medicines to improve patient outcomes. Additionally, the growing need for apheresis to treat a variety of disorders, such as acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and cardiac neonatal lupus, is one of the main factors driving the sector. Furthermore, the use of apheresis to obtain plasma for the treatment of burn and trauma patients is increasing globally. Both this and the quickly growing healthcare sector contribute to the industry's development.
Moreover, technology advancements for apheresis devices, such as automation, improved safety protocols, and better separation methods, are accelerating, enhancing safety, and simplifying processes. Advances in portable and user-friendly apheresis equipment also enable home-based therapies and other treatments outside of the hospital. These devices elevate the market & provide patients with flexibility by making therapy more accessible, especially for individuals who need frequent or ongoing apheresis, further states the research study, Apheresis Market Analysis, 2032.
Analyzing the Apheresis Market Segmentation
Express Delivery to Dominate the Apheresis Market
By Product, the Apheresis Market is bifurcated into: Apheresis Devices and Disposables.
It is expected that the Apheresis Devices would capture the biggest share of the Apheresis Market. Due to its several noteworthy benefits, it offers over-membrane separation technology, which is presumed to drive the centrifugation apheresis device market in 2023. Owing to their high efficiency in separating blood components, centrifugation apheresis devices are an increasingly popular option for therapeutic procedures among healthcare professionals seeking extensive therapies for a variety of conditions, such as leukemia, autoimmune disorders, and neurological diseases.
North America to Lead the Global Apheresis Market
Geographically, the Global Apheresis Market id foreseen to be led by North America. In the regional countries, there is a substantial frequency of chronic diseases and a significant patient population with hematological disorders. Additionally, there has been a noticeable surge in health investments as a result of these nations' rising per capita consumer spending. The rising economy is causing consumers to choose more advanced medications, which is propelling the growth of the North America Apheresis Market.
Apheresis Market Companies Analysis
With the strategic analysis & market study the leading companies, including B. Braun SE, Asahi Kasei Corporation, Fresenius SE & Co. KgaA, Haemonetics Corporation, Terumo Corporation, KANEKA CORPORATION, SB-KAWASUMI LABORATORIES, INC., Medica SPA, Nikkiso Co., Ltd., Cerus Corporation, Miltenyi Biotech, Haier Biomedical, Others, are predicted to contribute in the growing market outlook.